Fulcrum Therapeutics Inc (FULC) stock is up 52.84% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives FULC stock a score of 67 out of a possible 100. That rank is primarily influenced by a fundamental score of 95. In addition to the average rating from Wall Street analysts, FULC stock has a mean target price of $36.33. This means analysts expect the stock to increase 98.43% over the next 12 months. FULC's rank also includes a long-term technical score of 54. The short-term technical score for FULC is 53.
Fulcrum Therapeutics Inc (FULC) Stock Falls -8.50% This Week: Is It a Good Pick?
FULC has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on FULC!